Related references
Note: Only part of the references are listed.NK/T Cell Lymphoma: Updates in Therapy
Ritsuro Suzuki
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma
Shinichi Makita et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
The diagnosis and management of NK/T-cell lymphomas
Eric Tse et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA
J-H Liang et al.
BLOOD CANCER JOURNAL (2017)
Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL
S. H. Lim et al.
BONE MARROW TRANSPLANTATION (2016)
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET ONCOLOGY (2016)
Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China
Rong Liang et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase
Liang Wang et al.
ONCOTARGET (2015)
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment
A. A. Gru et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2015)
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET HAEMATOLOGY (2015)
Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance
Y-L Kwong et al.
LEUKEMIA (2014)
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy
Zhao-Yang Wang et al.
BLOOD (2012)
Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
Yoshinori Ito et al.
CLINICAL CANCER RESEARCH (2012)
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
Ritsuro Suzuki et al.
BLOOD (2011)
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au et al.
BLOOD (2009)
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
Hyo Song Kim et al.
LEUKEMIA & LYMPHOMA (2009)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
